DermTech, Inc. announced that Dr. John Dobak expects to step away from his role as chief executive officer under a planned transition. Dr. John Dobak will continue to serve as chief executive officer until the earlier of the date the Board appoints a successor and September 30, 2023. The Board has initiated a comprehensive search to identify Dr. Dobak's replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1455 USD | -56.24% | -54.53% | -91.69% |
18/06 | Sector Update: Health Care Stocks Edge Up Late Afternoon | MT |
18/06 | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-91.69% | 50.87L | |
-9.10% | 1.16TCr | |
-9.72% | 764.67Cr | |
+30.85% | 562.33Cr | |
-15.68% | 384.67Cr | |
+8.97% | 261.99Cr | |
-64.67% | 236.66Cr | |
-11.30% | 223.75Cr | |
+24.87% | 216.31Cr | |
-9.38% | 176.46Cr |
- Stock Market
- Equities
- DMTK Stock
- News DermTech, Inc.
- DermTech, Inc. Announces John Dobak Expects to Step Away as Chief Executive Officer